These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7659325)

  • 21. Clinical and bacteriologic impact of rifabutin prophylaxis for Mycobacterium avium complex infection in patients with human immunodeficiency virus infection.
    Maslo C; Buré-Rossier A; Girard PM; Gholizadeh Y; Lebrette MG; Rozenbaum W
    Clin Infect Dis; 1997 Mar; 24(3):344-9. PubMed ID: 9114183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rifabutin prophylaxis against Mycobacterium avium complex infections in HIV-infected patients: impact on the incidence of campylobacteriosis.
    Pulik M; Genet P; Leturdu F; Lionnet F; Louvel D; Touahri T
    AIDS Patient Care STDS; 1999 Aug; 13(8):467-72. PubMed ID: 10800525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is rifabutin prophylaxis against Mycobacterium avium complex infection in HIV infection worthwhile? The net impact on patients suggests not.
    Stephenson JM; Williams IG
    Genitourin Med; 1996 Aug; 72(4):272-6. PubMed ID: 8976833
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current status in the prevention of Mycobacterium avium complex infections in patients with HIV infection].
    Doco-Lecompte T; Brel F; May T; Perronne C
    Ann Med Interne (Paris); 1997; 148(2):167-71. PubMed ID: 9238443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylaxis of mycobacterial infection and acquired drug resistance.
    Böttger EC; Böttger O; Stichnoth DO
    J Antimicrob Chemother; 1997 Jul; 40(1):145-6. PubMed ID: 9249224
    [No Abstract]   [Full Text] [Related]  

  • 26. Rifabutin-associated uveitis during prophylaxis for Mycobacterium avium complex infection.
    Rifai A; Peyman GA; Daun M; Wafapoor H
    Arch Ophthalmol; 1995 Jun; 113(6):707. PubMed ID: 7786206
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ansatipine: only preventive treatment available for opportunistic MAI infections in AIDS. From an interview with Dr. Agnes Mignon].
    Mignon A
    Allerg Immunol (Paris); 1994 Apr; 26(4):148, 151-3. PubMed ID: 8031460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rifabutin.
    Med Lett Drugs Ther; 1993 Apr; 35(895):36-8. PubMed ID: 8386302
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease.
    Hewitt RG; Papandonatos GD; Shelton MJ; Hsiao CB; Harmon BJ; Kaczmarek SR; Amsterdam D
    AIDS; 1999 Jul; 13(11):1367-72. PubMed ID: 10449290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corneal endothelial deposits in children positive for human immunodeficiency virus receiving rifabutin prophylaxis for Mycobacterium avium complex bacteremia.
    Arevalo JF; Freeman WR
    Am J Ophthalmol; 2000 Mar; 129(3):410-1. PubMed ID: 10755956
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of MAI infections in AIDS with Ansatipine: experience at a hospital. From an interview with Dr. Jean-Luc Meynard].
    Meynard JL
    Allerg Immunol (Paris); 1994 Apr; 26(4):155-7. PubMed ID: 8031462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Against the proposition: all patients with advanced HIV disease should be offered rifabutin prophylaxis.
    Pozniak A; Nelson MR
    Genitourin Med; 1996 Aug; 72(4):269-71. PubMed ID: 8976832
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prophylaxis against opportunistic microorganisms].
    Rogowska-Szadkowska D
    Przegl Epidemiol; 2001; 55 Suppl 3():100-8. PubMed ID: 11984935
    [No Abstract]   [Full Text] [Related]  

  • 35. Azithromycin effective in preventing MAC.
    AIDS Alert; 1996 Oct; 11(10):120. PubMed ID: 11363857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
    Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
    Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic options for the management and prevention of Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome.
    Tartaglione TA
    Pharmacotherapy; 1996; 16(2):171-82. PubMed ID: 8820462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycobacterium avium intracellulare infection in patients with HIV or AIDS.
    Brettle RP
    J Antimicrob Chemother; 1997 Aug; 40(2):156-60. PubMed ID: 9301979
    [No Abstract]   [Full Text] [Related]  

  • 39. [The stakes in preventing opportunistic MAI infections in AIDS. From an interview with Dr. Patrick Philibert].
    Philibert P
    Allerg Immunol (Paris); 1994 Apr; 26(4):145-8. PubMed ID: 7913323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azithromycin in the prophylaxis of opportunistic infections in AIDS.
    McCutchan JA
    Int J STD AIDS; 1996; 7 Suppl 1():34-7. PubMed ID: 8652726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.